Brief: ALK-Abello's Itulazax Approved For Treatment Of Children In Europe
April 23 (Reuters) - ALK-Abello A/S ALKb.CO: ITULAZAX TREE POLLEN TABLET APPROVED FOR TREATMENT OF CHILDREN IN EUROPE FIRST MARKET INTRODUCTIONS TO FOLLOW IN COMING MONTHS APPROVAL IS NOT EXPECTED TO AFFECT ALK'S FINANCIAL OUTLOOK FOR 2025 Source text: ID:nGNEp5Y3F Further company coverage: [ALKb.CO] (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))